|
|
| Base-case Analysis | Monte Carlo simulation | |
| Mean | Median | |||
| Costs (CNY) | Nivolumab + chemotherapy | 778470.78 | 777897.17 | 764293.86 |
|
| Chemotherapy alone | 204725.62 | 206570.26 | 203128.18 |
| Utilities (QALYs) | Nivolumab + chemotherapy | 10.08 | 9.24 | 8.73 |
|
| Chemotherapy alone | 7.93 | 7.17 | 6.55 |
| ICUR (CNY/QALY) |
| 267498.67 | 275160.04 | 256613.79 |